Photo Rounds

Painful lumps in the axilla

Author and Disclosure Information

 

References

Intralesional steroid injections with triamcinolone 10 mg/mL can reduce local pain and inflammation rapidly. Pain management is also critical, as HS is painful. First-line therapy includes nonsteroidal anti-inflammatory drugs, acetaminophen, atypical anticonvulsants, and serotonin and norepinephrine reuptake inhibitors.2 Opiate analgesics may be needed for breakthrough pain in patients with severe disease. Avoiding tight clothing, harsh products, and adhesive dressings, as well as using clear petroleum jelly, can prevent skin trauma and help with healing. Weight loss and smoking cessation are also associated with better outcomes.6,7

If medical management fails …

If there is no improvement with medical management, it may be time to consider local procedures such as unroofing/deroofing, punch debridement, skin-tissue-sparing excision with electrosurgical peeling, and laser excision. Incision and drainage may be necessary for acutely inflamed, painful abscesses but should not be routinely performed because lesions can recur.3

Referral to a plastic surgeon is necessary when patients are considering wide excisions of largely affected areas. Even when surgical excisions are performed, medical treatment is needed to prevent new lesions and recurrences.

Our patient was treated initially with oral doxycycline 100 mg bid and intralesional triamcinolone (10 mg/mL) in the most tender lesions. He was also provided with a prescription for ibuprofen 800 mg tid to be taken with meals. The family physician encouraged the patient to lose weight. The patient derived some benefit from treatment but continued to experience new painful lesions.

Hidradenitis suppurativa is painful, and thus, pain management is critical.

The physician prescribed oral clindamycin 300 mg bid at a follow-up visit to replace the oral doxycycline. When this failed, the patient was sent for labs to determine if he would be a candidate for adalimumab. When the screening labs were normal, a prescription for adalimumab was provided: 160 mg subcutaneously at Week 0, 80 mg at Week 2, and then 40 mg weekly.4

Pages

Recommended Reading

FDA issues warning about use of dermal fillers with needle-free devices
MDedge Family Medicine
PDT for actinic keratoses continues to be refined
MDedge Family Medicine
Study of biologics’ impact on psoriasis-to-PsA transition contradicts previous findings
MDedge Family Medicine
9-step ladder may kids with allergies return to eggs
MDedge Family Medicine
FDA OKs iPLEDGE change for gender-neutral language
MDedge Family Medicine
Fecal microbiota transplants may improve resistance to melanoma immunotherapy
MDedge Family Medicine
Itchy vesicles
MDedge Family Medicine
European agency supports marketing of abrocitinib for atopic dermatitis
MDedge Family Medicine
Adalimumab biosimilar Cyltezo gets interchangeability designation
MDedge Family Medicine
‘Multimorbidity’ more commonly seen in people with lupus
MDedge Family Medicine